VHL and head and neck squamous cell carcinoma: Next, we replaced the E3 ubiquitin ligase of TSM-1 with Von Hippel-Lindau (VHL) and found that the conjugation of VHL with TSN seriously decreased its solubility, resulting in poor efficacy on HNSCC and CRC cells, so TSM-1 was selected for further research.